Latent Tuberculosis: Lack of Awareness Raises Future Infection Concerns
- Public health officials and medical researchers are emphasizing the critical need for increased awareness and screening of latent tuberculosis infection (LTBI) to prevent the future emergence of active...
- Latent tuberculosis infection is a state where a person is infected with TB bacteria, but the bacteria remain inactive.
- The primary concern with LTBI is the potential for the bacteria to become active and multiply, which leads to the development of active TB disease.
Public health officials and medical researchers are emphasizing the critical need for increased awareness and screening of latent tuberculosis infection (LTBI) to prevent the future emergence of active TB disease. While national spread of tuberculosis is currently not significant, the prevalence of the latent form of the condition presents a long-term risk for potential future infections.
Latent tuberculosis infection is a state where a person is infected with TB bacteria, but the bacteria remain inactive. According to the Centers for Disease Control and Prevention (CDC), individuals with LTBI have a small number of TB bacteria in their bodies that are alive but inactive, meaning they do not feel sick and cannot spread the bacteria to others.
Understanding the Risk of Progression
The primary concern with LTBI is the potential for the bacteria to become active and multiply, which leads to the development of active TB disease. The CDC estimates that up to 13 million people in the United States have latent TB infection.
Without medical treatment, approximately 5% to 10% of people with LTBI will develop active TB disease over their lifetimes. This progression from untreated latent infection to active disease accounts for roughly 80% of TB cases in the United States.
The risk of reactivation is particularly high for individuals with immunocompromising conditions. LTBI is defined as a persistent immune response to Mycobacterium tuberculosis antigens without evidence of clinically manifested active disease.
Diagnosis and Identification
Identifying LTBI is challenging because those infected do not exhibit symptoms of illness. However, the CDC notes that people with latent TB infection typically show the following clinical markers:
- Positive results from TB blood tests or TB skin tests.
- Typically normal chest radiographs.
- Negative sputum smears and cultures.
Because these individuals do not require respiratory isolation and do not feel sick, they may remain unaware of their status without proactive screening.
Global and Local Challenges in Awareness
The lack of awareness regarding LTBI is a recognized barrier to tuberculosis control globally. A study published in Frontiers in Public Health on December 9, 2025, indicates that LTBI affects approximately one-quarter of the global population.
In high-burden settings, such as South Africa, public awareness remains limited. Research conducted in a rural Eastern Cape community found that educational exposure significantly improved the ability of participants to recognize LTBI as distinct from active TB and enhanced their understanding of the risks associated with disease progression.
The study noted that knowledge of LTBI was significantly higher among those with prior educational exposure, with 77% of educated participants showing higher knowledge compared to 46% of those without such exposure.
Prevention and Treatment Strategies
Medical guidance emphasizes that treating latent TB infection substantially reduces the risk that the infection will progress to active TB disease. Finding and treating those with LTBI is considered essential for the control and eventual elimination of TB disease.
The detection and management of LTBI have become key components of the World Health Organization’s End TB Strategy, as well as the federal framework for TB prevention and control in Canada. These initiatives focus on identifying the reservoir of LTBI cases to prevent the transition to active disease.
Public health strategies now focus on improving care cascades, particularly in pediatric populations, where initial steps in the care process have been identified as lacking.